1 min read
Add as a preferred source on GoogleSunshine Biopharma Announces $6 Million Public Offering Pricing
The offering includes 10.9 million common units, with expected gross proceeds of about $6 million.
Sunshine Biopharma (SBFM) announced pricing for a public offering expected to generate about $6 million in gross proceeds, giving the company a new source of funding.
The offering includes 10.9 million common units.
The announcement was made Oct. 8, 2026.
John Kim
John Kim reports on the digital-asset business for TokenPost. Send corrections or tips to info@tokenpost.com.